Drawing for CELLINK

USPTO serial 87753836

CELLINK

Reviewed by CopyMark Law Group

Reg. 6121600Status 700Renewal
Filing date
Status date
Registration date
Aug 11, 2020
Examiner
BUTTON, JENNIFER JO
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CELLINK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,793*

Plus Government fees of $2,975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Margarita Wallach, Esq.

Margarita Wallach, Esq. McCarter & English, LLP250 W. 55th Street, 13th FloorNEW YORK, NY 10019United States

Goods and services

ClassDescriptionStatusFirst use
001Biologically compatible materials, namely, hydrogels used to create structures and scaffolds used in the manufacture of living tissue; Biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue; Biological tissue specimens for use in scientific research; Cellulose nanofibril based biological preparations for use in 3d bioprinting of tissues and organsACTIVE
005Biological tissue cultures for medical purposes; Tissue-regenerative pharmaceutical preparationsACTIVE
007Three-dimensional printers (3D printers); Three-dimensional bioprinters (3D bioprinters); Computer controlled 3D printers for the generation of three-dimensional shaped parts; Machines for manufacturing three dimensional models, namely, computer-aided modeling devices; computer-aided additive machines for manufacturing three-dimensional objects; machines for manufacturing three dimensional models, namely, computer-aided modeling devices and associated computer hardware and software sold as a unit; computer-aided additive machines for manufacturing three-dimensional objects and associated computer hardware and software sold as a unit; Machines for manufacturing three dimensional (3D) living tissues; machines, namely, three dimensional (3D) bioprinter for the printing of living tissues; cartridges for containing 3D printing material sold empty; cartridges for containing 3D bioprinting material sold empty; 3D printing cartridges for containing biomaterial sold empty; 3D printing cartridges for containing bioink sold emptyACTIVE
009Laboratory devices that can be used in biotechnology, and the pharmaceuticals and cosmetics industries for computer-assisted, three-dimensional dosing of biomaterials for the patient-friendly, biofunctional shaping of cell carrier structures, tissues, blood vessels, implants, prostheses and releasing systems for medicinal substances; Laboratory apparatus for fabrication of three dimensional (3D) living tissuesACTIVE
010Devices that can be used in medicine for computer-assisted, three-dimensional dosing of biomaterials for the patient-friendly, biofunctional shaping of cell carrier structures, tissues, blood vessels, implants, prostheses and releasing systems for medicinal substancesACTIVE
0403D printing services; Renting of 3D printers; Creation of customised three-dimensional shaped parts using rapid prototyping equipment; 3D Bioprinting; BioprintingACTIVE
042Research and development of 3D technology and processes; Development of rapid prototyping equipment; Technical consultancy relating to rapid prototyping development and research; Scientific research consulting in the fields of three-dimensional printing; Scientific services relating to the isolation and cultivation of human tissues and cellsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 11, 2026ES8RTEAS SECTION 8 RECEIVED
Aug 11, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 15, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 11, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 26, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 6, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 16, 2020EXPTEXPARTE APPEAL TERMINATED
Apr 16, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 12, 2020JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY
Jun 21, 2019GEA1NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Jun 21, 2019GECDACTION DENYING REQ FOR RECON E-MAILED
Jun 21, 2019CNCFACTION CONTINUING FINAL - COMPLETED
May 24, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 24, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2019ALIEASSIGNED TO LIE
May 15, 2019EXPIEX PARTE APPEAL-INSTITUTED
May 15, 2019JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY
May 15, 2019EXAFEXPARTE APPEAL RECEIVED AT TTAB
May 14, 2019ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 14, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Nov 14, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 14, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 9, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 9, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 9, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 9, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 9, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 9, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 6, 2018DOCKASSIGNED TO EXAMINER
Jan 26, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2018NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance